Calidad de eclosión para quistes de artemia de tres lugares del Perú

Se comparan quistes de artemia obtenidos en Tumbes, Huacho y Chilca con una variedad comercial del Gran Lago Salado, Utah, con respecto a porcentaje, eficiencia, tiempo y rendimiento de la eclosión. Las variedades de Tumbes y Huacho fueron de mejor calidad que la variedad comercial y la de Chilca.

Helsinki 31/8 1942

Kirje 31.8.1942

Sofrimento Psíquico e Vivência da Família com Paralisia Cerebral

O presente trabalho tem como tema o sofrimento psíquico e vivência da família com crianças com paralisia cerebral. Pretende-se, com este trabalho, fazer uma caracterização das famílias face ao diagnóstico, do sofrimento e vivência com uma criança com paralisia cerebral, compreender os sentimentos e quais as maiores dificuldades que essas famílias enfrentam no dia-a-dia para cuidar de uma criança com paralisia cerebral. Procuramos fazer um estudo qualitativo cujos fundamentos são relevantes a natureza da investigação pois a opção fundamenta na abordagem considerada mais pertinente tendo em vista os objectivos definidos. As respostas das entrevistas foram registadas e tratadas com base na análise de conteúdo que é entendida como um método de tratamento e análises de informações colhidas por meios de técnicas de colectas de dados, sintetizadas em um documento. O estudo revela que o confronto com o diagnóstico é um choque emocional tendo as famílias manifestado sintomas depressivos. Apesar desse choque, as famílias revelaram aceitar a situação e procurar ajuda e estratégias de enfrentamento da situação. Os resultados deste estudo revelam que, na maioria das famílias há uma luta enorme para ultrapassar essas dificuldades, o que pode ser explicado pelo facto delas estarem a ser ajudadas pela associação acarinhar, o que lhes permite aliviar os seus sofrimentos, tirar as dúvidas e encontrar o apoio e amparo necessários. O suporte social recebido tanto pela família como pelos amigos e profissionais de saúde pode ter sido fundamental para aliviar o sofrimento psicológico e possibilitar uma maior tomada de consciência da situação. Quanto as estratégias da vivência familiar essas famílias revelam mais centradas no problema.

Condición reproductiva y fecundidad de Vinciguerria lucetia pecific durante el crucero BIC Humboldt 9808-09

Describe el estado reproductivo de Vinciguerria lucetia pacifici a través del análisis histológico de ovarios por grados latitudinales. Se elabora una escala de madurez sexual de cinco estadíos. Durante la ejecución del Crucero 9808-09, efectuado entre el 20 de agosto y el 18 de setiembre de 1998 la Vinciguerria lucetia pacifici se encontró en plena etapa de desove. La talla de los individuos estuvo comprendida entre 3,5 y 7,0 cm de longitud total. Esta especie tiene un desarrollo ovocitario asincrónico y un tipo de desove parcial. Se estimó la fecundidad parcial promedio en 309 ovocitos por hembra (DS=164).

Electron microscopy of RecA-DNA complexes: Two different states, their functional significance and relation to the solved crystal structure

Seven different electron microscopy techniques habe been employed to study the RecA protein of E. coli. This review provides a summary of the conclusions that have been drawn from these studies, and attempts to relate these observations to models for the role of RecA protein in homologous recombination.

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

BACKGROUND: The use of n-3 fatty acids may prevent cardiovascular events in patients with recent myocardial infarction or heart failure. Their effects in patients with (or at risk for) type 2 diabetes mellitus are unknown. METHODS: In this double-blind study with a 2-by-2 factorial design, we randomly assigned 12,536 patients who were at high risk for cardiovascular events and had impaired fasting glucose, impaired glucose tolerance, or diabetes to receive a 1-g capsule containing at least 900 mg (90% or more) of ethyl esters of n-3 fatty acids or placebo daily and to receive either insulin glargine or standard care. The primary outcome was death from cardiovascular causes. The results of the comparison between n-3 fatty acids and placebo are reported here. RESULTS: During a median follow up of 6.2 years, the incidence of the primary outcome was not significantly decreased among patients receiving n-3 fatty acids, as compared with those receiving placebo (574 patients [9.1%] vs. 581 patients [9.3%]; hazard ratio, 0.98; 95% confidence interval [CI], 0.87 to 1.10; P=0.72). The use of n-3 fatty acids also had no significant effect on the rates of major vascular events (1034 patients [16.5%] vs. 1017 patients [16.3%]; hazard ratio, 1.01; 95% CI, 0.93 to 1.10; P=0.81), death from any cause (951 [15.1%] vs. 964 [15.4%]; hazard ratio, 0.98; 95% CI, 0.89 to 1.07; P=0.63), or death from arrhythmia (288 [4.6%] vs. 259 [4.1%]; hazard ratio, 1.10; 95% CI, 0.93 to 1.30; P=0.26). Triglyceride levels were reduced by 14.5 mg per deciliter (0.16 mmol per liter) more among patients receiving n-3 fatty acids than among those receiving placebo (P<0.001), without a significant effect on other lipids. Adverse effects were similar in the two groups. CONCLUSIONS: Daily supplementation with 1 g of n-3 fatty acids did not reduce the rate of cardiovascular events in patients at high risk for cardiovascular events. (Funded by Sanofi; ORIGIN ClinicalTrials.gov number, NCT00069784.).

Atrioventricular septal defects among infants in Europe: a population-based study of prevalence, associated anomalies, and survival.

OBJECTIVE: To describe the epidemiology of chromosomal and non-chromosomal cases of atrioventricular septal defects in Europe. METHODS: Data were obtained from EUROCAT, a European network of population-based registries collecting data on congenital anomalies. Data from 13 registries for the period 2000-2008 were included. RESULTS: There was a total of 993 cases of atrioventricular septal defects, with a total prevalence of 5.3 per 10,000 births (95% confidence interval 4.1 to 6.5). Of the total cases, 250 were isolated cardiac lesions, 583 were chromosomal cases, 79 had multiple anomalies, 58 had heterotaxia sequence, and 23 had a monogenic syndrome. The total prevalence of chromosomal cases was 3.1 per 10,000 (95% confidence interval 1.9 to 4.3), with a large variation between registers. Of the 993 cases, 639 cases were live births, 45 were stillbirths, and 309 were terminations of pregnancy owing to foetal anomaly. Among the groups, additional associated cardiac anomalies were most frequent in heterotaxia cases (38%) and least frequent in chromosomal cases (8%). Coarctation of the aorta was the most common associated cardiac defect. The 1-week survival rate for live births was 94%. CONCLUSION: Of all cases, three-quarters were associated with other anomalies, both chromosomal and non-chromosomal. For infants with atrioventricular septal defects and no chromosomal anomalies, cardiac defects were often more complex compared with infants with atrioventricular septal defects and a chromosomal anomaly. Clinical outcomes for atrioventricular septal defects varied between regions. The proportion of termination of pregnancy for foetal anomaly was higher for cases with multiple anomalies, chromosomal anomalies, and heterotaxia sequence.